HealthUSA

Discovered antibodies that block 100% coronavirus

Company Sorrento Therapeutics claims to have found an antibody that may make a person immune to COVID-19 or cure it for a few days. It is reported by the SUN.

CEO of Sorrento Therapeutics Henry JI said the company is”working day and night to complete the steps required for approval of this product”.

Researchers found Sorrento Therapeutics antibody, named STI-1499, after analysis of billions of antibodies and study of their interaction with the coronavirus.

Scientists have discovered that the STI-1499 associated with the coronavirus, it stops the reproduction and displays a virus from the human body for four days.

The company claims that with the introduction of the antibodies into the human body, which has no COVID-19, STI-1499 provides immunity.

“We want to emphasize that the cure is!, said JI in an interview with Fox News.

He also explained how the antibody STI-1499 “cures” the coronavirus.

“The virus can not survive if the antibody prevents its penetration into the human cell, said Dr. JI. – If the virus can’t penetrate the cells, they cannot reproduce. So this means that if we don’t give the virus to penetrate the cell, it will eventually die. [STI-1499] “hugs” the virus, enveloping him, and removes from the body”.

The results of the study should be tested on animals before they test on humans.

“There is a solution that works 100 %, – said JI. – If your body has a neutralizing antibody, you don’t need social distancing. You can open a society without fear”.

Antibody STI-1499 discovered in Sorrento Therapeutics, a biotech company in San Diego, California. Its stock rose at 138.6% within a few hours after the announcement.

Sorrento Therapeutics has partnered with the new York health System Mount Sinai to develop a cocktail of antibodies, to begin human trials in the third quarter.

Currently there are no approved treatments or vaccines approved for coronavirus. Several drug manufacturers are rushing to develop new methods to apply them to patient care.

The collaboration with Mount Sinai Sorrento Therapeutics gives access to a pool of antibodies against COVID-19, obtained from nearly 15,000 people.

The company Sorrento Therapeutics, which is developing several types of treatment, including four immuno-Oncology, said that completes the requirements for providing STI-1499 in control, the food and drug administration to begin testing on humans at an early stage.

For the development of vaccines often takes years, but researchers are trying to reach the goal in a matter of months.

Source:

usa.one

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Please disable your ad blocker

We know you are here for the stories. Not the ads. But we need the ads to keep the lights on. So please whitelist Buzzon.live.